Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 1
1984 2
1985 1
1986 3
1987 2
1988 5
1989 2
1990 3
1991 3
1992 2
1993 4
1994 5
1995 4
1996 4
1997 2
1998 4
1999 5
2000 2
2001 6
2002 3
2003 6
2004 7
2005 1
2006 5
2007 6
2008 3
2009 2
2010 3
2011 5
2012 2
2013 3
2014 3
2015 2
2016 2
2017 2
2018 4
2019 2
2020 2
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

124 results
Results by year
Filters applied: . Clear all
Page 1
Fibroblast growth factor-2 and cardioprotection.
Kardami E, Detillieux K, Ma X, Jiang Z, Santiago JJ, Jimenez SK, Cattini PA. Kardami E, et al. Among authors: cattini pa. Heart Fail Rev. 2007 Dec;12(3-4):267-77. doi: 10.1007/s10741-007-9027-0. Heart Fail Rev. 2007. PMID: 17516168 Review.
FGF-2 is also a potent angiogenic protein and a crucial agent for the proliferation, expansion, and survival of several cell types including those with stem cell properties. Human clinical trials have pointed to a good safety record for this protein. ...
FGF-2 is also a potent angiogenic protein and a crucial agent for the proliferation, expansion, and survival of several cell types including …
The hidden but positive role for glucocorticoids in the regulation of growth hormone-producing cells.
Vakili H, Cattini PA. Vakili H, et al. Among authors: cattini pa. Mol Cell Endocrinol. 2012 Nov 5;363(1-2):1-9. doi: 10.1016/j.mce.2012.08.001. Epub 2012 Aug 11. Mol Cell Endocrinol. 2012. PMID: 22910554 Review.
An examination of recent findings from elegant avian and gene ablation in mice studies as well as clinical case reports, suggests this is not the case. The evidence suggests that the effect of glucocorticoids on growth and GH production can be uncoupled, and reveals they p …
An examination of recent findings from elegant avian and gene ablation in mice studies as well as clinical case reports, suggests thi …
Mechanisms of glucocorticoid hormone action.
Slater EP, Anderson T, Cattini P, Isaacs R, Birnbaum MJ, Gardner DG, Eberhardt NL, Baxter JD. Slater EP, et al. Among authors: cattini p. Adv Exp Med Biol. 1986;196:67-80. doi: 10.1007/978-1-4684-5101-6_5. Adv Exp Med Biol. 1986. PMID: 3012984 Review.
The GRE on the human metallothionein-IIA gene is located in the 5'-flanking DNA. It can function independently of the gene's promoter, and when ligated upstream from the herpes simplex virus (HSV) thymidine kinase (TK) gene promoter, can activate it. ...
The GRE on the human metallothionein-IIA gene is located in the 5'-flanking DNA. It can function independently of the gene's promoter …
Fibroblast growth factor 2 isoforms and cardiac hypertrophy.
Kardami E, Jiang ZS, Jimenez SK, Hirst CJ, Sheikh F, Zahradka P, Cattini PA. Kardami E, et al. Among authors: cattini pa. Cardiovasc Res. 2004 Aug 15;63(3):458-66. doi: 10.1016/j.cardiores.2004.04.024. Cardiovasc Res. 2004. PMID: 15276471 Review.
Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity.
Koleini N, Santiago JJ, Nickel BE, Sequiera GL, Wang J, Fandrich RR, Jassal DS, Dhingra S, Kirshenbaum LA, Cattini PA, Kardami E. Koleini N, et al. Among authors: cattini pa. Am J Physiol Heart Circ Physiol. 2019 Feb 1;316(2):H279-H288. doi: 10.1152/ajpheart.00587.2018. Epub 2018 Nov 9. Am J Physiol Heart Circ Physiol. 2019. PMID: 30412444 Free article.
Beyond angiogenesis: the cardioprotective potential of fibroblast growth factor-2.
Detillieux KA, Cattini PA, Kardami E. Detillieux KA, et al. Among authors: cattini pa. Can J Physiol Pharmacol. 2004 Dec;82(12):1044-52. doi: 10.1139/y04-126. Can J Physiol Pharmacol. 2004. PMID: 15644945 Review.
Here, we look beyond the angiogenic potential of FGF-2 and examine its acute cardioprotective activity as demonstrated under experimental conditions, both as an agent of a preconditioning-like response and for secondary injury prevention at the time of reperfusion. Factors to con …
Here, we look beyond the angiogenic potential of FGF-2 and examine its acute cardioprotective activity as demonstrated under experimental co …
124 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page